I know this is gonna sound hilarious, but I am actually researching for a friend. Seriously, I’m a nurse in New York. My friend, age 73 and suffering from end stage copd. He’s on oxygen and tells me his O2 level has dropped in the 60’s — very dangerous levels. He has passed out before. Anyway, he has been taking CBD about a month and has little effects (positive or negative). He is slowly increasing the amount but is now experiencing “bad taste” for the past three days. As one who has never smoked or ingested CBD’s, I’m at a loss. Any suggestions?
Customer Service: It’s difficult to find contact information on Calm by Wellness’s website, and their email address is listed incorrectly in two places (we tried sending them an email but it was not delivered). We were, however, able to get a response through Facebook, and the company does offer free shipping and a generous 30-day return policy on all orders.
Your nose and taste symptoms sound similar to a smell disorder. Parosmia and Phantosmia sometimes can happen from colds or sinusitis. You could lose you sense of smell or start smelling things that aren’t there from damage to the olfactory nerve. Other possible causes are post concussion syndrome, temporal lobe epilepsy, and early stages of Parkinson’s disease and dementia. In any case, you should get this checked out with a doctor to rule out the serious stuff. I have been living with Phantosmia for seven years from a concussion. I use a pure CBD extract with no added oils – it does taste like crap so I put it in food.
A study published in 1986 in the International Journal of Neuroscience, examined the effects of CBD oil in 5 patients with dystonic movement disorders (muscle tremors and other forms of uncontrollable movements). CBD oil’s side effects “were mild and included hypotension [low blood pressure], dry mouth, psychomotor slowing [slowed thoughts or movements], lightheadedness, and sedation,” according to the study’s authors, Paul Consroe, Reuven Sandyk and Stuart R. Snider.
Disclaimer: The Federal Food, Drug, and Cosmetic Act requires this disclaimer. We collected this information from various sources for the convenience of our customers. The statements made regarding these products were not evaluated by the Food and Drug Administration. The efficacy of these products is not confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. The information presented here is not meant as a substitute for information from health care practitioners. It is also not meant as an alternative to information from health care practitioners. Before using any product, you should consult your doctor and ask about the risk of interactions or complications.
The results of most of the studies were describing a favorable safety profile of CBD and it was extensively confirmed by research done on humans. Most of these studies performed treatments for patients either suffering from epilepsy or psychotic disorders. The most common side effects to be reported were tiredness, diarrhea, and changes in appetite/weight.
CBD shows promise in the treatment of anxiety disorders, according to a report published in the journal Neurotherapeutics in 2015. Looking at results from experimental research, clinical trials, and epidemiological studies, the report’s authors found evidence that CBD may help treat generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. However, the authors caution that human-based research on CBD and anxiety is fairly limited at this point.
Like any medications, overdosing can lead to potential risks for pets. “The most significant is THC toxicity, meaning, essentially, they are high,” Richter says. “Depending on how significantly a pet has been overdosed, the effects of that can be quite long-lasting, even days.” During these episodes, a pet may not be able to stand or eat. If you suspect an overdose, take your pet to the veterinarian immediately.
The law on hemp-based products in the United States has evolved a lot in recent years. The federal farm bill of 2014 permitted the sale of hemp products, providing that the psychoactive content of these products (i.e. the amount of THC) was below 0.3 percent. That’s why you so often see references to products being either “THC-free” or containing less than 0.3 percent.
Success stories like Oliver’s are everywhere, but there’s not a lot of data to back up those results. That’s because CBD comes from cannabis and, like nearly all other parts of the plant, is categorized by the Drug Enforcement Agency (DEA) as a Schedule 1 drug—the most restrictive classification. (Others on that list: heroin, Ecstasy, and peyote.) This classification, which cannabis advocates have tried for years to change, keeps cannabis-derived products, including CBD, from being properly studied in the U.S.
In addition to acting on the brain, CBD influences many body processes. That’s due to the endocannabinoid system (ECS), which was discovered in the 1990s, after scientists started investigating why pot produces a high. Although much less well-known than the cardiovascular, reproductive, and respiratory systems, the ECS is critical. “The ECS helps us eat, sleep, relax, forget what we don’t need to remember, and protect our bodies from harm,” Marcu says. There are more ECS receptors in the brain than there are for opioids or serotonin, plus others in the intestines, liver, pancreas, ovaries, bone cells, and elsewhere.